OptimizeRx Corporation (OPRX)
USD 7.32
(-5.61%)
USD 7.32
(-5.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 42.89 Million USD | 10.09% |
| 2022 | 38.96 Million USD | 9.34% |
| 2021 | 35.63 Million USD | 47.84% |
| 2020 | 24.1 Million USD | 56.13% |
| 2019 | 15.43 Million USD | 26.48% |
| 2018 | 12.2 Million USD | 105.06% |
| 2017 | 5.95 Million USD | 37.16% |
| 2016 | 4.34 Million USD | 20.61% |
| 2015 | 3.59 Million USD | 9.66% |
| 2014 | 3.28 Million USD | 2.88% |
| 2013 | 3.18 Million USD | 64.98% |
| 2012 | 1.93 Million USD | 73.94% |
| 2011 | 1.11 Million USD | 1464.09% |
| 2010 | 71.06 Thousand USD | 102.71% |
| 2009 | -2.62 Million USD | -3231.15% |
| 2008 | 83.68 Thousand USD | -16.58% |
| 2007 | 100.31 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 11.13 Million USD | -37.58% |
| 2024 Q2 | 10.63 Million USD | 5.09% |
| 2023 FY | 42.89 Million USD | 10.09% |
| 2023 Q3 | 9.8 Million USD | 25.24% |
| 2023 Q4 | 17.84 Million USD | 82.05% |
| 2023 Q1 | 7.43 Million USD | -40.32% |
| 2023 Q2 | 7.82 Million USD | 5.27% |
| 2022 Q1 | 8.1 Million USD | -34.62% |
| 2022 Q4 | 12.45 Million USD | 32.2% |
| 2022 FY | 38.96 Million USD | 9.34% |
| 2022 Q2 | 8.98 Million USD | 10.96% |
| 2022 Q3 | 9.42 Million USD | 4.79% |
| 2021 Q1 | 6.12 Million USD | -28.82% |
| 2021 FY | 35.63 Million USD | 47.84% |
| 2021 Q2 | 8.04 Million USD | 31.35% |
| 2021 Q3 | 9.07 Million USD | 12.83% |
| 2021 Q4 | 12.39 Million USD | 36.52% |
| 2020 Q1 | 4.34 Million USD | -2.91% |
| 2020 FY | 24.1 Million USD | 56.13% |
| 2020 Q3 | 6.01 Million USD | 16.91% |
| 2020 Q2 | 5.14 Million USD | 18.45% |
| 2020 Q4 | 8.6 Million USD | 43.06% |
| 2019 Q3 | 3.02 Million USD | -30.04% |
| 2019 FY | 15.43 Million USD | 26.48% |
| 2019 Q1 | 3.62 Million USD | -11.42% |
| 2019 Q4 | 4.47 Million USD | 48.03% |
| 2019 Q2 | 4.31 Million USD | 19.12% |
| 2018 Q4 | 4.09 Million USD | 30.1% |
| 2018 FY | 12.2 Million USD | 105.06% |
| 2018 Q3 | 3.14 Million USD | 9.91% |
| 2018 Q2 | 2.86 Million USD | 36.05% |
| 2018 Q1 | 2.1 Million USD | -16.61% |
| 2017 Q3 | 1.39 Million USD | 11.0% |
| 2017 Q4 | 2.52 Million USD | 80.37% |
| 2017 Q1 | 770.34 Thousand USD | -45.76% |
| 2017 Q2 | 1.26 Million USD | 63.6% |
| 2017 FY | 5.95 Million USD | 37.16% |
| 2016 Q1 | 866.73 Thousand USD | -19.84% |
| 2016 Q3 | 1.06 Million USD | 7.3% |
| 2016 Q2 | 990.46 Thousand USD | 14.28% |
| 2016 Q4 | 1.42 Million USD | 33.63% |
| 2016 FY | 4.34 Million USD | 20.61% |
| 2015 Q2 | 823.13 Thousand USD | 12.59% |
| 2015 Q4 | 1.08 Million USD | 12.28% |
| 2015 Q3 | 962.99 Thousand USD | 16.99% |
| 2015 FY | 3.59 Million USD | 9.66% |
| 2015 Q1 | 731.11 Thousand USD | -7.15% |
| 2014 Q3 | 761.31 Thousand USD | -16.72% |
| 2014 Q4 | 787.41 Thousand USD | 3.43% |
| 2014 FY | 3.28 Million USD | 2.88% |
| 2014 Q1 | 818.53 Thousand USD | 24.51% |
| 2014 Q2 | 914.16 Thousand USD | 11.68% |
| 2013 FY | 3.18 Million USD | 64.98% |
| 2013 Q1 | 629.08 Thousand USD | 315.89% |
| 2013 Q4 | 657.41 Thousand USD | -34.01% |
| 2013 Q2 | 906.88 Thousand USD | 44.16% |
| 2013 Q3 | 996.19 Thousand USD | 9.85% |
| 2012 Q2 | 439.21 Thousand USD | 33.34% |
| 2012 Q1 | 329.4 Thousand USD | 1.07% |
| 2012 FY | 1.93 Million USD | 73.94% |
| 2012 Q4 | -291.39 Thousand USD | -167.38% |
| 2012 Q3 | 432.48 Thousand USD | -1.53% |
| 2011 Q3 | -99.44 Thousand USD | -7.16% |
| 2011 Q1 | 318.4 Thousand USD | 2470.68% |
| 2011 Q2 | -92.8 Thousand USD | -129.15% |
| 2011 Q4 | 325.91 Thousand USD | 427.72% |
| 2011 FY | 1.11 Million USD | 1464.09% |
| 2010 Q1 | 1283.00 USD | 100.05% |
| 2010 Q3 | 40.67 Thousand USD | 143.28% |
| 2010 FY | 71.06 Thousand USD | 102.71% |
| 2010 Q2 | 16.72 Thousand USD | 1203.2% |
| 2010 Q4 | 12.38 Thousand USD | -69.55% |
| 2009 Q4 | -2.63 Million USD | -38200.23% |
| 2009 FY | -2.62 Million USD | -3231.15% |
| 2009 Q3 | 6908.00 USD | 101.98% |
| 2009 Q2 | -348.56 Thousand USD | -27524.39% |
| 2009 Q1 | 1271.00 USD | -91.73% |
| 2008 Q1 | 50.52 Thousand USD | 0.0% |
| 2008 Q3 | 1111.00 USD | -93.34% |
| 2008 Q2 | 16.67 Thousand USD | -66.99% |
| 2008 FY | 83.68 Thousand USD | -16.58% |
| 2008 Q4 | 15.36 Thousand USD | 1283.35% |
| 2007 FY | 100.31 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CareCloud, Inc. | 46.24 Million USD | 7.227% |
| Augmedix, Inc. | 21.52 Million USD | -99.293% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 97.008% |
| CareCloud, Inc. | 46.24 Million USD | 7.227% |
| HealthEquity, Inc. | 622.63 Million USD | 93.11% |
| iCoreConnect Inc. | 6.12 Million USD | -600.7% |
| Inovalon Holdings, Inc. | 499.7 Million USD | 91.415% |
| Nutex Health, Inc. | 34.77 Million USD | -23.367% |
| Omnicell, Inc. | 499.92 Million USD | 91.419% |
| OneMedNet Corporation | -127.9 Thousand USD | 33641.765% |
| Progyny, Inc. | 238.79 Million USD | 82.035% |
| Renalytix Plc | 156 Thousand USD | -27399.947% |
| Schrödinger, Inc. | 140.69 Million USD | 69.508% |
| Simulations Plus, Inc. | 43.15 Million USD | 0.582% |
| SOPHiA GENETICS SA | 42.91 Million USD | 0.03% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | -271.653% |
| Ontrak, Inc. | 8.8 Million USD | -387.499% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 99.458% |
| Sharecare, Inc. | 129.49 Million USD | 66.872% |
| Aclarion, Inc. | -324.00 USD | 13240815.123% |
| CareMax, Inc. | 13.9 Million USD | -208.61% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -71638.992% |
| Forian Inc. | 15 Million USD | -185.918% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -71638.992% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | 29.234% |
| SCWorx Corp. | 1.26 Million USD | -3280.4% |
| Minerva Surgical, Inc. | 27.24 Million USD | -57.477% |
| Definitive Healthcare Corp. | 203.93 Million USD | 78.964% |
| 10x Genomics, Inc. | 409.31 Million USD | 89.519% |
| Zhongchao Inc. | 8.51 Million USD | -403.982% |
| Accolade, Inc. | 192.06 Million USD | 77.663% |
| MSP Recovery, Inc. | 5.56 Million USD | -671.581% |
| R1 RCM Inc. | 484.5 Million USD | 91.146% |
| Spok Holdings, Inc. | 112.2 Million USD | 61.767% |
| Privia Health Group, Inc. | 161.5 Million USD | 73.437% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -4994.548% |
| TruBridge, Inc. | 163.56 Million USD | 73.772% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 97.008% |
| Sharecare, Inc. | 129.49 Million USD | 66.872% |
| Health Catalyst, Inc. | 131.83 Million USD | 67.459% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 93.722% |
| Premier, Inc. | 840.73 Million USD | 94.897% |
| HealthStream, Inc. | 184.04 Million USD | 76.69% |
| Certara, Inc. | 213.31 Million USD | 79.889% |
| GeneDx Holdings Corp. | 60.62 Million USD | 29.234% |
| Ontrak, Inc. | 8.8 Million USD | -387.499% |
| SHL Telemedicine Ltd. | 25.26 Million USD | -69.827% |
| CareCloud, Inc. | 46.24 Million USD | 7.227% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -4994.548% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -9842.02% |
| CareMax, Inc. | 13.9 Million USD | -208.61% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -533.022% |
| National Research Corporation | 86.66 Million USD | 50.5% |
| Aclarion, Inc. | -324.00 USD | 13240815.123% |